Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Fosun Pays $607 Million for Portuguese Hospital Chain

publication date: Oct 13, 2014
Fosun International has won a takeover battle for a 51% stake Espirito Santo Saude, a Portuguese chain of hospitals, clinics and nursing homes. Fosun upped its bid to $607 million, raising the price 4% from its previous offer of 4.82 euros per share to 5.01. Fosun's latest bid narrowly tops the 5 euro offer from UnitedHealth of the US, one of Fosun's chief rivals in the drama. The competition between bidders underscores the desire of investors to own hospital assets. More details....

Stock Symbol: (HK: 656)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital